OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The safety of NOACs in atrial fibrillation patient subgroups: A narrative review
Gregory Y.H. Lip
International Journal of Clinical Practice (2018) Vol. 73, Iss. 2, pp. e13285-e13285
Open Access | Times Cited: 15

Showing 15 citing articles:

Rivaroxaban in patients with mechanical heart valves: A pilot study
Eva Roost, Alberto Weber, Lorenzo Alberio, et al.
Thrombosis Research (2019) Vol. 186, pp. 1-6
Closed Access | Times Cited: 26

Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups
Bariş Gencer, Alon Eisen, David Berger, et al.
American Heart Journal (2022) Vol. 247, pp. 24-32
Open Access | Times Cited: 15

Individualised prediction of major bleeding in patients with atrial fibrillation treated with anticoagulation
Anne Pernille Toft‐Petersen, Christina Ji‐Young Lee, Matthew Phelps, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0312294-e0312294
Open Access | Times Cited: 1

Characteristics and Mechanism of Acute Ischemic Stroke in NAVF Patients With Prior Oral Anticoagulant Therapy
Sufang Xue, Risu Na, Jing Dong, et al.
The Neurologist (2023) Vol. 28, Iss. 6, pp. 379-385
Open Access | Times Cited: 3

Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stenting
Sergio Buccheri, Dominick J. Angiolillo, Davide Capodanno
Therapeutic Advances in Cardiovascular Disease (2019) Vol. 13
Open Access | Times Cited: 7

A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents
Gaetano Giuffrida, Uroš Markovic, Daniela Nicolosi, et al.
Clinical Case Reports (2020) Vol. 9, Iss. 2, pp. 623-628
Open Access | Times Cited: 3

Plasma Drug Values of DOACs in Patients Presenting with Gastrointestinal Bleeding: A Prospective Observational Study
Dorotea Božić, Damir Aličić, Dinko Martinović, et al.
Medicina (2023) Vol. 59, Iss. 8, pp. 1466-1466
Open Access | Times Cited: 1

Use of NOACS in high-risk patients with atrial fibrillation in Saudi Arabia: Perspectives on improving patient care
Naeem Alshoaibi, Mousa Al Harbi, H Modaimegh, et al.
Expert Review of Cardiovascular Therapy (2021) Vol. 19, Iss. 3, pp. 221-236
Closed Access | Times Cited: 3

Optimal Antithrombotic Therapy in Patients with Atrial Fibrillation During Percutaneous Coronary Intervention
О. Л. Барбараш, В. В. Кашталап
Doctor Ru (2020) Vol. 19, Iss. 5, pp. 6-13
Open Access | Times Cited: 2

New oral anticoagulants in nonvalvular atrial fibrillation
Svetlana Apostolović, Dragana Stanojević, Tomislav Kostić
Galenika Medical Journal (2022) Vol. 1, Iss. 1, pp. 22-27
Open Access

Recanalization rate of proximal deep venous thrombosis related to therapeutic modality during six months follow-up
Alden Begić, Edin Begić, Mirza Dilić, et al.
Medicinski Glasnik (2022) Vol. 19, Iss. 2, pp. 134-139
Open Access

The safety of new oral anticoagulants for ischemic stroke and systemic embolism prevention in females with atrial fibrillation
Despina-Manuela Toader, Ileana Neacă, A Paraschiv, et al.
Romanian Journal of Neurology (2021) Vol. 20, Iss. 1, pp. 5-14
Open Access


Despina-Manuela Toader, Ileana Neacă, A Paraschiv, et al.
Romanian Journal of Neurology (2021) Vol. 20, Iss. 1
Open Access

Page 1

Scroll to top